Trial Profile
Evaluation of the efficacy of Xeomin in the treatment of cervical dystonia (CD) and blepharospasmus (BS) in patients who did not respond to treatment with Botox.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Torticollis
- Focus Therapeutic Use
- 03 Aug 2012 New trial record